The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-(2-((5-nitrofuran-2-yl)methylene)hydrazinyl)quinoxaline ID: ALA4636697
PubChem CID: 156012854
Max Phase: Preclinical
Molecular Formula: C13H9N5O3
Molecular Weight: 283.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccc(/C=N/Nc2cnc3ccccc3n2)o1
Standard InChI: InChI=1S/C13H9N5O3/c19-18(20)13-6-5-9(21-13)7-15-17-12-8-14-10-3-1-2-4-11(10)16-12/h1-8H,(H,16,17)/b15-7+
Standard InChI Key: HNLATXRZQNFZQX-VIZOYTHASA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
2.7019 -10.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7008 -11.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4088 -11.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4070 -9.9174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1156 -10.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1164 -11.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8249 -11.5488 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5332 -11.1379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5285 -10.3158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8194 -9.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2337 -9.9029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9439 -10.3072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6491 -9.8943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3593 -10.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4507 -11.1088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2510 -11.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6553 -10.5636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1048 -9.9598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4703 -10.4734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7981 -9.7248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9547 -11.1315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
19 20 2 0
19 21 1 0
17 19 1 0
M CHG 2 19 1 21 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 283.25Molecular Weight (Monoisotopic): 283.0705AlogP: 2.58#Rotatable Bonds: 4Polar Surface Area: 106.45Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.47CX Basic pKa: 1.54CX LogP: 2.81CX LogD: 2.81Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.45Np Likeness Score: -1.99
References 1. Maranhão SS, Moura AF, Oliveira ACA, Lima DJB, Barros-Nepomuceno FWA, Paier CRK, Pinheiro AC, Nogueira TCM, de Souza MVN, Pessoa C.. (2020) Synthesis of PJOV56, a new quinoxalinyl-hydrazone derivative able to induce autophagy and apoptosis in colorectal cancer cells, and related compounds., 30 (2): [PMID:31836446 ] [10.1016/j.bmcl.2019.126851 ]